FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 122,342,805
- Total 13F shares
- 122,159,363
- Share change
- -920,692
- Total reported value
- $400,671,566
- Put/Call ratio
- 93%
- Price per share
- $3.28
- Number of holders
- 176
- Value change
- -$37,762,295
- Number of buys
- 90
- Number of sells
- 70
Quarterly Holders Quick Answers
What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31189P102:
Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
|
Company |
11%
|
13,169,057
|
$96,660,878 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.1%
|
9,911,007
|
$72,746,792 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7.4%
|
9,099,951
|
$66,793,642 | — | 31 Mar 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
6.7%
|
8,215,910
|
$60,304,779 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
6.6%
|
8,036,669
|
$58,989,150 | — | 31 Mar 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
4.6%
|
5,572,607
|
$40,902,935 | — | 31 Mar 2024 | |
| Bellevue Group AG |
13F
|
Company |
4%
|
4,839,779
|
$35,523,978 | — | 31 Mar 2024 | |
| JOHNSON & JOHNSON |
13F
|
Company |
2.8%
|
3,379,064
|
$24,802,330 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.6%
|
3,131,526
|
$22,985,401 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.5%
|
3,065,789
|
$22,502,891 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.2%
|
2,730,966
|
$20,045,290 | — | 31 Mar 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
2,562,852
|
$18,811,334 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2.1%
|
2,548,304
|
$18,704,551 | — | 31 Mar 2024 | |
| Holocene Advisors, LP |
13F
|
Company |
2.1%
|
2,527,747
|
$18,553,663 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.8%
|
2,190,408
|
$16,077,595 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.7%
|
2,140,000
|
$15,707,600 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.6%
|
2,012,258
|
$14,769,973 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.6%
|
1,999,822
|
$14,678,693 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.6%
|
1,919,776
|
$14,091,156 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
1,905,983
|
$13,991,921 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.5%
|
1,892,002
|
$13,887,295 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.5%
|
1,818,181
|
$13,345,449 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.4%
|
1,759,321
|
$12,913,416 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.4%
|
1,714,124
|
$12,581,000 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.3%
|
1,584,300
|
$11,628,762 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.2%
|
1,437,700
|
$10,552,718 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.1%
|
1,355,352
|
$9,948,284 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.87%
|
1,063,179
|
$7,803,734 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.82%
|
1,007,378
|
$7,394,155 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.79%
|
965,431
|
$7,086,263 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.78%
|
956,331
|
$7,019,470 | — | 31 Mar 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.75%
|
920,476
|
$6,756,294 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.72%
|
886,925
|
$6,510,028 | — | 31 Mar 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.71%
|
870,000
|
$6,385,800 | — | 31 Mar 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.65%
|
800,000
|
$5,872,000 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.6%
|
729,657
|
$5,355,682 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.59%
|
716,052
|
$5,255,822 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.57%
|
700,000
|
$5,138,000 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.51%
|
623,058
|
$4,573,246 | — | 31 Mar 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.43%
|
520,800
|
$3,822,672 | — | 31 Mar 2024 | |
| GCM Grosvenor Holdings, LLC |
13F
|
Company |
0.41%
|
495,916
|
$3,640,023 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.38%
|
460,000
|
$3,376,400 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.36%
|
444,050
|
$3,259,327 | — | 31 Mar 2024 | |
| J. Scott Wolchko |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
871,248
mixed-class rows
|
$2,987,354 | — | 01 Feb 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.31%
|
383,201
|
$2,812,695 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.31%
|
378,608
|
$2,778,983 | — | 31 Mar 2024 | |
| Artal Group S.A. |
13F
|
Company |
0.29%
|
360,311
|
$2,644,683 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.28%
|
345,437
|
$2,535,508 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.27%
|
324,243
|
$2,379,945 | — | 31 Mar 2024 | |
| Monaco Asset Management SAM |
13F
|
Company |
0.26%
|
316,805
|
$2,325,349 | — | 31 Mar 2024 |
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q2 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.